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Abstract. Drugmonitoring is usually performed by liquid chromatography coupled with
optical detection or electrospray ionization mass spectrometry. More recently, matrix-
assisted laser desorption/ionization (MALDI) in combination with triple quadrupole or
Fourier-transform (FT) mass analyzers has also been reported to allow accurate
quantification. Here, we present a strategy that employs standard MALDI time-of-flight
(TOF) mass spectrometry (MS) for the sensitive and accurate quantification of
saquinavir from an extract of blood peripheral mononuclear cells. Unambiguous
identification of saquinavir in the mass spectra was possible because of using internal
mass calibration and by an overall low chemical noise in the low mass range. Exact
mass determination of the constant background peaks of the cell extract, which were
used for recalibration, was performed by an initial MALDI-FT-MSanalysis. Fast andmultiplexed sample analysiswas
enabled by microarray technology, which provided 10 replicates in the lower nL range for each sample in parallel
lanes ona chip. In order to validate themethod,we employed various statistical tests, such as confidence intervals for
linear regressions, three quality control samples, and inverse confidence limits of the estimated concentration ratios.
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Introduction
The limiting factors in the analysis of antiretroviral drugsare the minute amounts of blood peripheral mononuclear
cells (PBMCs) from patients that are available, as well as the
complex sample matrix from cell lysates. Therefore, highly
sensitive as well as selective detection methods are required.
“Gold standards” rely on “high performance” liquid chromatog-
raphy (HPLC) in combination with UV detection or electrospray
mass spectrometry (ESI-MS) [1–3]. However, sample through-
put is limited because of the long cycle times of chromatographic
runs. By contrast, usingMALDI-MS, the analysis of one sample
(i.e., one spot) merely takes a few seconds and, therefore, high-
throughput analysis is possible. MALDI-MS also is less
demanding with respect to sample preparation or purification
and allows preferred ionization of selected classes of compounds
depending on the used MALDI matrix. On the other hand,
MALDI-MS is usually not the method of choice for quantitative
applications [4–6]. Nevertheless, in recent years improvements
in sample preparation by introducing modified sample targets or
protocols, have efficiently addressed this problem. Furthermore,
MALDI instrumentation using triple quadrupole and FT-MS
analyzers is increasingly used for quantitative applications and
has also been mentioned in clinical drug monitoring [7–15].
Here, we report on a method to quantify saquinavir from a cell
extract using standardMALDI-TOF-MS.We performed an initial
high resolutionmass scan of the cell background using aMALDI-
FT-MS. Sample analysis was carried out by MALDI-TOF-MS,
where spectra were recalibrated using background peaks from
reserpine and the cell extract. The overall noise level (e.g.,
obtained by matrix clusters or fragments) was found to be quite
low, although α-cyano-4-hydroxycinnamic acid (CHCA) was
used as theMALDImatrix (Supplementary InformationFigure 1).
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Importantly, the method presented relies on the assistance of
microarray plates, which feature multiple lanes of small
hydrophilic spots. The plates support the analysis of a large
number of replicates, which in turn increases confidence. To
evaluate the performance of our method, we plotted the 95%
confidence interval for the calibration series above and below the
curve fitted by linear regression. The correlation coefficient (r2)
was evaluated by plotting all data points measured for the
calibration, instead of using average values.
Experimental
Chemicals
Alpha-cynao-4-hydroxycinnamic acid (CHCA), saquinavir,
atazanavir, indinavir, nelfinavir, and reserpine were pur-
chased from Sigma Aldrich (Buchs, Switzerland).
Microarrays and Sliding Device
Microarray targets (MAMS,Microarrays forMass Spectrometry,
Supplementary Information Figure 2) were produced as previ-
ously described. In brief, the targets were made of ITO-coated
microscope glass slides with an omniphobic polysilazane coating
on top. Lanes of microarray spots with a diameter of 400 or
500 μmand a cavity of 35 μmwere prepared by picosecond laser
ablation [4, 16]. ITO slides were mounted onto a standard AB
SCIEX sample target carrier using a metal mask that was
prepared in-house. The sliding device was produced in-house and
is made of stainless steel. It consists of an approximately 10 cm
long edge and supporting bars on a guiding rail. The edge is
positioned sufficiently low so as to contact the series of droplets
that are located in the deposition spots. Then, the slider drags the
droplets from the deposition spot over the lanes. Each time the
droplet passes over a hydrophilic spot, a nanoliter aliquot is
retained, thus generating multiple replicates from one droplet. In
total, many replicates can be produced by one sliding motion (the
microarray target used herein generated 12 replicates per sample).
Cell Extract
PBMCs were purchased from ZenBio and lysed as described
by van Kampen et al. [11]. In brief, 1 million cells were lysed in
100 μL of 50% ethanol. Lysis was performed without agitation
over night at 5ºC. Cells were centrifuged at 14,000 g at 5°C for
10 min, and the supernatant was collected and brought to 20%
EtOH in H2O. The cell lysate was further purified using
OasisHLB (Waters, London, UK) extraction columns. The
eluate from the extraction columnswas dried using a speed-vac,
redissolved in 10 μL spike solution (50% acetonitrile in H2O),
internal standard was added, and the samples were mixed with
MALDI matrix solution at a ratio of 1 to 2 (v/v).
Sample Aliqouting
Amixture of 4.5 μLwas pipetted onto the “deposition reservoir”
of each lane and aliquoted using ametal slider as described in the
materials and methods section as well as in Pabst et al. 2013 [4].
CHCA was used as a MALDI matrix at a concentration of 4 mg
per mL in 60% acetonitrile and 40%H2O, (v/v) with 0.1% TFA.
The slider and microarray target were cooled to 4°C for at least
15 min before aliquoting. This was found to be beneficial to
prevent the samples of the nanoliter volumes from drying too
fast. Aliquoting was carried out at the laboratory bench,
maintaining a constant speed of the slider.
MALDI Mass Spectrometry
MALDI mass spectra were recorded on a commercial instrument
(ABSCIEXTOF/TOF™ 5800System,Darmstadt, Germany). For
MALDI-MS analysis, the whole spot was scanned with a circular
scan pattern of 120 individual positions and 20 shots per position
(2400 shots in total per spot) at a repetition rate of 1000 Hz,
detected in positive reflectron mode. Laser energy was set to 3800
(arbitrary units, as defined by the AB SCIEX software). Spectra
were averaged and relative signal areas calculated by dividing the
signal area of saquinavir by that of reserpine. The concentration
ratios were then used for generating the calibration curve. Internal
mass calibration of the MALDI-MS instrument was carried out
using peaks from reserpine and constant background signals. Exact
masses were obtained by measuring one reference sample with
internal calibration on aBruker SolariX, as described in Steinhoff et
al. [17]. All 12 replicates of each data point were measured. The
first and last spots of each row were used for performing MS/MS
experiments and for tuning the MALDI-TOF-MS instrument.
Internal Standards and Generation of Calibration
Curves
As an internal standard for saquinavir, we used reserpine; for
atazanavir and nelfinavir, we used indinavir, and for
indinavir, nelfinavir was chosen. Five-point calibration
curves of standard solutions (in 50% acetonitrile) were
acquired for all antiretroviral drugs between concentrations
of 15.6 and 2000 ng per mL.
Saquinavir was also quantified from an extract of blood
peripheral mononuclear cells, using reserpine as an internal
standard. The estimation of the concentration ratios of the
quality control samples for saquinavir was carried out using an
external calibration method. Ten μL of standard solutions with
concentrations of 15.6, 125, 500, 1500, 3000, and 4000 ng/mL
with a constant concentration of 750 ng/mL reserpine were
spiked to a cell extract of 1×106 cells. If we assume a volume
of 0.4 pL per cell [18], these concentrations would translate
into PBMC concentrations of 0.39, 3.125, 12.5, 37.5, 75, and
100 ng/mL. As estimated in Pabst et al. 2013 [4], each array
spot contains approximately 10 nL. Therefore, the lowest
concentration (15.6 ng per mL) equals an absolute amount of
approximately 250 attomol saquinavir per array spot.
Data Analysis
Data extraction from MALDI-TOF analysis results was carried
out using the analysis tool of the TOF/TOFseries Explorer
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software from AB SCIEX. Calculation of the 95% confidence
interval, r2, curve of the linear regression, and inverse confidence
limits for quality control samples were all done using Microsoft
Excel. All points (i.e., the whole data cloud) were plotted for data
analysis as opposed to averaging all points for a given
concentration. The formulae for inverse confidence limits were
taken from Szajli et al. [19] and Eisenhart et al. [20]. Outlier tests
were performed using a Q-test, for which up to one data point
was allowed to be treated as an outlier per 10 data points.
Results and Discussion
In a first set of experiments, we evaluated the sensitivity and
usefulness of our system for the analysis of selected antiretro-
viral drugs (saquinavir, atazanavir, indinavir, and nelfinavir)
using CHCA (Supplementary Information Figure 3). By using
the microarray, we obtained quite low levels of chemical noise
in the low m/z range, which was vital for the unambiguous
assignment of analyte signals that are close to the limit of
quantification (Fig. 1, Supplementary Information Figure 1).
We were able to obtain calibration curves with low standard
deviations and r2 values greater than 0.98 for all antiretroviral
drugs (Supplementary Information Figure 3).
We finally evaluated the practicability of employing
standard MALDI-TOF-MS for quantifying saquinavir in the
complex matrix of a cell extract. In a single pre-scan, we
determined the accurate masses of the constant background
peaks by MALDI-FT-MS once and chose four peaks close to
the mass of saquinavir [(M+H)+=679.1] for further internal
calibration of the MALDI-TOF-MS spectra (Supplementary
Information Figure 4). Therefore, it was not necessary to add
other internal standards, which might have resulted in a loss of
sensitivity because of competitive ionization. Saquinavir was
identified within a 10 ppm mass window, even at the lowest
concentration (Supplementary Information Table 1). Mass
resolution for the MALDI-TOF-MS instrument was found to
be about 10,000 (FWHM). Moreover, the identity of the
analytes was confirmed by additional MS/MS experiments.
Average standard deviations, mass accuracy, and signal-to-
noise ratios for the data points of the calibration curve can be
found in Supplementary Information Table 1). Alongside the
calibration curve, we analyzed three quality-control samples for
saquinavir. For this, we obtained relative standard deviations for
the replicate measurements of 4.5%, 3.1%, and 3.3% for the
lowest concentration (1.5 ng/mL). The accuracy for the
independent quality control samples were further found to be
Figure 2. Calibration curve obtained after plotting the whole
data series for saquinavir spiked to extracts of PBMCs (n = 10
per data point). The series was linear between 0.39 ng/mL and
100 ng/mL (volume of PBMCs expressed in mL); 95%
confidence intervals for the curve of best fit are outlined as
orange lines. The r2 value was calculated considering the whole
data series in the plot (n = 60) in graph. Points for quality control
samples (1–3) are marked with blue arrows
Figure 1. Mass spectra series from 0.39 ng/mL and 100 ng/mL
(volume PBMCs) plotted. A zoom of the two lowest concentra-
tions is presented below. Saquinavir is highlighted with orange
bars. Reserpine, which was used as internal standard, is
highlighted with a green bar
Table 1. Relative signal intensities of saquinavir for three quality control samples
Arel Estimated conc. St. dev. (RSD %) Nominal conc. Accuracy 95% Inverse Mass accuracy (ppm) Signal-to-noise ratio
saquinavir saquinavir
(ASaq./ARes) ng/mL (n=10) ng/mL % error confidence limits [M+H]
+=671.4 [M+H]+=671.4
2.010 53.28 2.4 (4.54%) 50.0 6.5 0.97 2.57 3166
1.027 27.25 0.84 (3.1%) 25.0 9.0 0.97 2.97 2094
0.046 1.29 0.04 (3.29%) 1.5 17.1 1.03 9.8 485
Estimated concentrations were within 6.5% and 17.1% relative error of the nominal values. Standard deviations of the repeated measurements are relatively
low and confidence limits of the estimated sample concentration appear narrow. Mass accuracy was found within 10 ppm even for the lowest concentration
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6.5% (53.28±2.4 ng/mL), 9% (27.25±0.84 ng/mL), and 17%
(1.29±0.04 ng/mL) (Table 1 and Supplementary Information
Figure 5). As expected for a confident analysis, the confidence
intervals of the curve of best fit and calculated 95% inverse
confidence limits according, to Szajli et al. [19] and Eisenhart et
al. [20], appeared very narrow (Fig. 2, Supplementary Informa-
tion Figure 6). We attribute the high data quality to the large
number of replicates (n=60 for the calibration curve, plus 10 for
the quality control sample), and the overall low standard
deviations of the MALDI-MS analysis (on average 3.9%,
Supplementary Information Table 1). In the theoretical case
of using a much lower number of replicates (e.g., n=18 for
the calibration curve if three replicates per data point are
acquired), both confidence limits would increase drastically,
even if standard deviations and the correlation of the
regression curve might be acceptable. Confidence limits,
therefore, allow a reliable decision to be made on the
quality of the results of the analysis [19]. The whole chip
was aliquoted within a few seconds (six calibration points
and three quality control samples). Furthermore, we were
able to acquire 10 replicates in approximately 1.5 min,
which is much faster than what can be reached by methods
involving chromatographic separations.
Conclusions
By combining a suitable sample preparation with microarray
technology and internal mass calibration, we demonstrated
that accurate, precise, and confident quantification of
antiretroviral drugs can be achieved by using standard
MALDI-TOF-MS. A single pre-scan of the accurate masses
as well as a low background signal noise in the lower mass
range allowed ambiguous peak assignment and quantifica-
tion from a complex matrix (Figs. 1 and 2).
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